✓ Translated by DotMD AI Clinical Council Source: Journal of oral rehabilitation • Randomized Controlled Trial

Verify Primary Source: NIH PubMed PMID #39305048 ↗

Randomized Controlled Trial: Impact of a mandibular advancement device on corticomotor plasticity in patients with obstructive sleep apnea (N = 28)

Original Paper Title: “Impact of a mandibular advancement device on corticomotor plasticity in patients with obstructive sleep apnea”

Elena Rostova (AI Quant) Rigor Score

88 / 100

Sample Size (Participants)

N = 28

Evidence Classification

Randomized Controlled Trial

Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways

Excitability of the masseter and tongue motor pathways is, at least transiently, increased in patients with OSA following a short-term use of MAD. This novel finding of MAD-induced neuroplasticity in corticomotor pathways may contribute to a further understanding of the mechanisms of oral appliances for treating OSA.
Study Design & Sample: Randomized Controlled Trial published in Journal of oral rehabilitation (N = 28 human participants).
Biostatistical Rigor Score: 88/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

Published in Journal of oral rehabilitation (2024), this randomized controlled trial evaluating 28 human participants investigated: Neuroplasticity induced by mandibular advancement appliance (MAD) in patients with obstructive sleep apnoea (OSA) is poorly documented. Key clinical takeaway: Excitability of the masseter and tongue motor pathways is, at least transiently, increased in patients with OSA following a short-term use of MAD. This novel finding of MAD-induced neuroplasticity in corticomotor pathways may contribute to a further understanding of the mechanisms of oral appliances for treating OSA.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (Journal of oral rehabilitation, 2024-12-15; N = 28; Rigor 88/100): Excitability of the masseter and tongue motor pathways is, at least transiently, increased in patients with OSA following a short-term use of MAD. This novel finding of MAD-induced neuroplasticity in corticomotor pathways may contribute to a further understanding of the mechanisms of oral appliances for treating OSA.

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Randomized Controlled Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Rx: muscle-rub-cream-menthol-10-methyl-salicylate-15 → Condition: sleep-apnea → Condition: parasomnia → Condition: confusional-arousals →

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 39305048: Randomized Controlled Trial: Impact of a mandibular advancement device on corticomotor plasticity in patients with obstructive sleep apnea (N = 28)

3 of 3 Free Questions Remaining